Summary
In 2011, NANOKER identified a potential business in developing a solution specifically addressed to patients with periodontal or peri-implant disease, the most prevalent form of bone pathology in humans, which affects 50% of adult population. The tremendous effects of...
More information & hyperlinks
Web resources: | http://www.inperio.es/ |